| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |